rawfin.tv
4D Molecular Therapeutics Files Form 144 for Stock Sale
MarketsstocksAI Generated

4D Molecular Therapeutics Files Form 144 for Stock Sale

By rawfin.tv Markets Desk||Updated |1 min read|AI-assisted · Methodology

Investing.com reports on a Form 144 filing for 4D Molecular Therapeutics (FDMT) on October 5th. This filing indicates an insider's intent to sell restricted shares of the company's stock.

4D Molecular TherapeuticsForm 144insider tradingstock filingbiotech

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks